Phase I-II trial of alpha-difluoromethylornithine (DFMO) [MDL 71,782] and mitoguazone (MGBG) in hormone refractory prostatic cancer (PC) Meeting Abstract


Authors: Scher, H.; Smart-Curley, T.; Heston, W. D. W.; Reuter, V.; Sternberg, C.; Dershaw, D.; Pliner, L.; Yagoda, A.; Fair, W.
Abstract Title: Phase I-II trial of alpha-difluoromethylornithine (DFMO) [MDL 71,782] and mitoguazone (MGBG) in hormone refractory prostatic cancer (PC)
Meeting Title: 79th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Proceedings of the American Association for Cancer Research Annual Meeting
Volume: 29
Meeting Dates: 1988 May 25-28
Meeting Location: New Orleans, LA
ISSN: 0197-016X
Publisher: American Association for Cancer Research  
Date Published: 1988-03-01
Start Page: 204
Language: English
ACCESSION: WOS:A1988N264700810
PROVIDER: wos
Notes: Meeting Abstract: 810 -- Source: Wos
MSK Authors
  1. Warren Heston
    136 Heston
  2. D David Dershaw
    223 Dershaw
  3. Victor Reuter
    1228 Reuter
  4. Howard Scher
    1130 Scher
  5. William R Fair
    342 Fair
  6. Alan Yagoda
    51 Yagoda